Correlation Between Okta and Cansino Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Okta and Cansino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and Cansino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and Cansino Biologics, you can compare the effects of market volatilities on Okta and Cansino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of Cansino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and Cansino Biologics.

Diversification Opportunities for Okta and Cansino Biologics

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Okta and Cansino is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and Cansino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cansino Biologics and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with Cansino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cansino Biologics has no effect on the direction of Okta i.e., Okta and Cansino Biologics go up and down completely randomly.

Pair Corralation between Okta and Cansino Biologics

Given the investment horizon of 90 days Okta Inc is expected to generate 0.89 times more return on investment than Cansino Biologics. However, Okta Inc is 1.12 times less risky than Cansino Biologics. It trades about 0.03 of its potential returns per unit of risk. Cansino Biologics is currently generating about -0.05 per unit of risk. If you would invest  6,189  in Okta Inc on August 27, 2024 and sell it today you would earn a total of  1,468  from holding Okta Inc or generate 23.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy96.17%
ValuesDaily Returns

Okta Inc  vs.  Cansino Biologics

 Performance 
       Timeline  
Okta Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Okta Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Cansino Biologics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Cansino Biologics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Cansino Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.

Okta and Cansino Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Okta and Cansino Biologics

The main advantage of trading using opposite Okta and Cansino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, Cansino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cansino Biologics will offset losses from the drop in Cansino Biologics' long position.
The idea behind Okta Inc and Cansino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
FinTech Suite
Use AI to screen and filter profitable investment opportunities